Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics

Cancer and Metastasis Reviews

Volumn 25, Issue 4, 2006, Pages 677-694

  Ji, Rui Cheng ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Intratumoral lymphatics; Lymphangiogenesis; Lymphatic endothelial cells; Peritumoral lymphatics; Tumor metastasis; VEGF C D VEGFR 3

Indexed keywords

5' NUCLEOTIDASE; ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DESMOPLAKIN; INTERCELLULAR ADHESION MOLECULE 1; MOLECULAR MARKER; PODOPLANIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR FOXC2; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; VON WILLEBRAND FACTOR;

ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MICROENVIRONMENT; MORPHOLOGICAL TRAIT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE PRESSURE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846180704     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-9026-y     Document Type: Review

References (120)

1. Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-257.
2. Achen, M. G., McColl, B. K., & Stacker, S. A. (2005). Focus on lymphangiogenesis in tumor metastasis. Cancer Cells, 7, 121-127.
3. Alitalo, K., Tammela, T., & Petrova, T. V. (2005). Lymphangiogenesis in development and human disease. Nature, 438, 946-953.
4. Ji, R. C. (2005). Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histology and Histopathology, 20, 155-175.
5. Ji, R. C. (2006). Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphatic Research and Biology, 4, 83-100.
6. Kato, S., Shimoda, H., Ji, R. C., & Miura, M. (2006). Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anatomical Science International, 81, 71-83.
7. Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., et al. (2002). Lymphatic metastasis in the absence of functional intratumor lymphatics. Science, 296, 1883-1886.
8. Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., et al. (2003). Tumor lymphangiogenesis: A novel prognostic indicator for cutaneous melanoma metastasis and survival. American Journal of Pathology, 162, 1951-1960.
9. Krishnan, J., Kirkin, V., Steffen, A., Hegen, M., Weih, D., Tomarev, S., et al. (2003). Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Research, 63, 713-722.
10. Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., et al. (2001). Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. American Journal of Pathology, 159, 893-903.
11. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., et al. (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Medicine, 7, 192-198.
12. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., et al. (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Medicine, 7, 186-191.
13. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Yla-Herttuala, S., Jaattela, M., et al. (2001). Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Research, 61, 1786-1790.
14. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO Journal, 20, 672-682.
15. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., et al. (2002). Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. American Journal of Pathology, 161, 947-956.
16. Rubbia-Brandt, L., Terris, B., Giostra, E., Dousset, B., Morel, P., & Pepper, M. S. (2004). Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clinical Cancer Research, 10, 6919-6928.
17. Gombos, Z., Xu, X., Chu, C. S., Zhang, P. J., & Acs, G. (2005). Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clinical Cancer Research, 11, 8364-8371.
18. Maula, S. M., Luukkaa, M., Grenman, R., Jackson, D., Jalkanen, S., & Ristamaki, R. (2003). Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Research, 63, 1920-1926.
19. Cursiefen, C., Ikeda, S., Nishina, P. M., Smith, R. S., Ikeda, A., Jackson, D., et al. (2005). Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. American Journal of Pathology, 166, 1367-1377.
20. Witte, M. H., Jones, K., Wilting, J., Dictor, M., Selg, M., McHale, N., et al. (2006). Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Reviews, 25, 159-184.
21. Leu, A. J., Berk, D. A., Lymboussaki, A., Alitalo, K., & Jain, R. K. (2000). Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation. Cancer Research, 60, 4324-4327.
22. He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., et al. (2005). Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Research, 65, 4739-4746.
23. Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002). Lymphangiogenesis and cancer metastasis. Nature Reviews. Cancer, 2, 573-583.
24. Kyzas, P. A., Geleff, S., Batistatou, A., Agnantis, N. J., & Stefanou, D. (2005). Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. Journal of Pathology, 206, 170-177.
25. Alitalo, K., & Carmeliet, P. (2002). Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cells, 1, 219-227.
26. Swartz, M. A., & Skobe, M. (2001). Lymphatic function, lymphangiogenesis, and cancer metastasis. Microscopy Research and Technique, 55, 92-99.
27. Goldman, J., Le, T. X., Skobe, M., & Swartz, M. A. (2005). Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circulation Research, 96, 1193-1199.
28. Nathanson, S. D. (2003). Insights into the mechanisms of lymph node metastasis. Cancer, 98, 413-423.
29. Isaka, N., Padera, T. P., Hagendoorn, J., Fukumura, D., & Jain, R. K. (2004). Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Research, 64, 4400-4404.
30. He, Y., Rajantie, I., Ilmonen, M., Makinen, T., Karkkainen, M. J., Haiko, P., et al. (2004). Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Research, 64, 3737-3740.
31. Cao, R., Bjorndahl, M. A., Gallego, M. I., Chen, S., Religa, P., Hansen, A. J., et al. (2006). Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood, 107, 3531-3536.
32. Cao, R., Bjorndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., et al. (2004). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cells, 6, 333-345.
33. Zlotnik, A. (2004). Chemokines in neoplastic progression. Seminars in Cancer Biology, 14, 181-185.
34. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
35. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., et al. (2004). CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity, 21, 279-288.
36. Qu, P., Ji, R. C., & Kato, S. (2003). Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice. Journal of Anatomy, 203, 523-530.
37. Qu, P., Ji, R. C., Shimoda, H., Miura, M., & Kato, S. (2004). Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy. The Anatomical Record. Part A, Discoveries in Molecular, Cellular and Evolutionary Biology, 281, 1326-1336.
38. Qu, P., Ji, R. C., & Kato, S. (2005). Expression of CCL21 and 5′-Nase on pancreatic lymphatics in nonobese diabetic mice. Pancreas, 31, 148-155.
39. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., et al. (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. Journal of Cell Biology, 144, 789-801.
40. Jackson, D. G. (2003). The lymphatics revisited: New perspectives from the hyaluronan receptor LYVE-1. Trends in Cardiovascular Medicine, 13, 1-7.
41. Moldovan, N. I., Goldschmidt-Clermont, P. J., Parker-Thornburg, J., Shapiro, S. D., & Kolattukudy, P. E. (2000). Contribution of monocytes/macrophages to compensatory neovascularization: The drilling of metalloelastase-positive tunnels in ischemic myocardium. Circulation Research, 87, 378-384.
42. Pytowski, B., Goldman, J., Persaud, K., Wu, Y., Witte, L., Hicklin, D. J., et al. (2005). Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. Journal of the National Cancer Institute, 97, 14-21.
43. Williams, C. S., Leek, R. D., Robson, A. M., Banerji, S., Prevo, R., Harris, A. L., et al. (2003). Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. Journal of Pathology, 200, 195-206.
44. Sipos, B., Kojima, M., Tiemann, K., Klapper, W., Kruse, M. L., Kalthoff, H., et al. (2005). Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. Journal of Pathology, 207, 301-312.
45. Kerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., et al. (2004). Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Journal of the American Society of Nephrology, 15, 603-612.
46. Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M. G., Hicklin, D. J., et al. (2005). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. Journal of Clinical Investigation, 115, 247-257.
47. Kerjaschki, D. (2005). The crucial role of macrophages in lymphangiogenesis. Journal of Clinical Investigation, 115, 2316-2319.
48. Ogawa, E., Takenaka, K., Yanagihara, K., Kurozumi, M., Manabe, T., Wada, H., et al. (2004). Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. British Journal of Cancer, 91, 498-503.
49. Ji, R. C., Qu, P., & Kato, S. (2003). Application of a new 5′-Nase monoclonal antibody specific for lymphatic endothelial cells. Laboratory Investigation, 83, 1681-1683.
50. Ji, R. C., Miura, M., Qu, P., & Kato, S. (2004). Expression of VEGFR-3 and 5′-Nase in regenerating lymphatic vessels of the cutaneous wound healing. Microscopy Research and Technique, 64, 279-286.
51. Ji, R. C., & Kato, S. (2001). Histochemical analysis of lymphatic endothelial cells in lymphostasis. Microscopy Research and Technique, 55, 70-80.
52. Ji, R. C., & Kato, S. (2003). Lymphatic network and lymphangiogenesis in the gastric wall. Journal of Histochemistry and Cytochemistry, 51, 331-338.
53. Farnsworth, R. H., Achen, M. G., & Stacker, S. A. (2006). Lymphatic endothelium: An important interactive surface for malignant cells. Pulmonary Pharmacology & Therapeutics, 19, 51-60.
54. Ji, R. C., & Kato, S. (2000). Intrinsic interrelation of lymphatic endothelia with nerve elements in the monkey urinary bladder. Anatomical Record, 259, 86-96.
55. Azzali, G. (2006). On the transendothelial passage of tumor cell from extravasal matrix into the lumen of absorbing lymphatic vessel. Microvascular Research, 72, 74-85.
56. Djonov, V., Andres, A. C., & Ziemiecki, A. (2001). Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microscopy Research and Technique, 52, 182-189.
57. Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., et al. (1999). Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. American Journal of Pathology, 154, 385-394.
58. Wigle, J. T., & Oliver, G. (1999). Prox1 function is required for the development of the murine lymphatic system. Cell, 98, 769-778.
59. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., et al. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Sciences of the United States of America, 92, 3566-3570.
60. Kato, S., & Miyauchi, R. (1989). Enzyme-histochemical visualization of lymphatic capillaries in the mouse tongue: Light and electron microscopic study. Okajimas Folia Anatomica Japonica, 65, 391-403.
61. Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., Williams, L. T. (1998). A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 95, 258-263.
62. Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002). A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nature Medicine, 8, 751-755.
63. Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., et al. (2002). Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Developmental Cell, 3, 411-423.
64. Albelda, S. M., Muller, W. A., Buck, C. A., & Newman, P. J. (1991). Molecular and cellular properties of PECAM-1 (endo-CAM/CD31): A novel vascular cell-cell adhesion molecule. Journal of Cell Biology, 114, 1059-1068.
65. Krause, D. S., Fackler, M. J., Civin, C. I., & May, W. S. (1996). CD34: Structure, biology, and clinical utility. Blood, 87, 1-13.
66. Sauter, B., Foedinger, D., Sterniczky, B., Wolff, K., & Rappersberger, K. (1998). Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. Journal of Histochemistry and Cytochemistry, 46, 165-176.
67. Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O., & Ruiter, D. J. (1985). Monoclonal antibody PAL-E specific for endothelium. Laboratory Investigation, 52, 71-76.
68. Kahn, H. J., & Marks, A. (2002). A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Laboratory Investigation, 82, 1255-1257.
69. Schmelz, M., Moll, R., Kuhn, C., & Franke, W. W. (1994). Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells: II. Different types of lymphatic vessels. Differentiation, 57, 97-117.
70. Erhard, H., Rietveld, F. J., Brocker, E. B., de Waal, R. M., & Ruiter, D. J. (1996). Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. Journal of Investigative Dermatology, 106, 135-140.
71. Dagenais, S. L., Hartsough, R. L., Erickson, R. P., Witte, M. H., Butler, M. G., & Glover, T. W. (2004). Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expression Patterns, 4, 611-619.
72. Petrova, T. V., Karpanen, T., Norrmen, C., Mellor, R., Tamakoshi, T., Finegold, D., et al. (2004). Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nature Medicine, 10, 974-981.
73. Wagner, D. D., Olmsted, J. B., & Marder, V. J. (1982). Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. Journal of Cell Biology, 95, 355-360.
74. Miettinen, M., Lindenmayer, A. E., & Chaubal, A. (1994). Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Modern Pathology, 7, 82-90.
75. Trzewik, J., Mallipattu, S. K., Artmann, G. M., Delano, F. A., & Schmid-Schonbein, G. W. (2001). Evidence for a second valve system in lymphatics: Endothelial microvalves. FASEB Journal, 15, 1711-1717.
76. Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997). Solid stress inhibits the growth of multicellular tumor spheroids. Nature Biotechnology, 15, 778-783.
77. Zeng, Y., Opeskin, K., Baldwin, M. E., Horvath, L. G., Achen, M. G., Stacker, S. A., et al. (2004). Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clinical Cancer Research, 10, 5137-5144.
78. Pettersson, A., Nagy, J. A., Brown, L. F., Sundberg, C., Morgan, E., Jungles, S., et al. (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Laboratory Investigation, 80, 99-115.
79. Beasley, N. J., Prevo, R., Banerji, S., Leek, R. D., Moore, J., van Trappen, P., et al. (2002). Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Research, 62, 1315-1320.
80. Crnic, I., Strittmatter, K., Cavallaro, U., Kopfstein, L., Jussila, L., Alitalo, K., et al. (2004). Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Research, 64, 8630-8638.
81. Papoutsi, M., Siemeister, G., Weindel, K., Tomarev, S. I., Kurz, H., Schachtele, C., et al. (2000). Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochemistry and Cell Biology, 114, 373-385.
82. Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005). VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. Journal of Experimental Medicine, 201, 1089-1099.
83. Hoon, D. S., Kitago, M., Kim, J., Mori, T., Piris, A., Szyfelbein, K., et al. (2006). Molecular mechanisms of metastasis. Cancer Metastasis Reviews, 25, 203-220.
84. Shields, J. D., Borsetti, M., Rigby, H., Harper, S. J., Mortimer, P. S., Levick, J. R., et al. (2004). Lymphatic density and metastatic spread in human malignant melanoma. British Journal of Cancer, 90, 693-700.
85. Bjorndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., et al. (2005). Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Research, 65, 9261-9268.
86. Nagy, J. A., Vasile, E., Feng, D., Sundberg, C., Brown, L. F., Detmar, M. J., et al. (2002). Vascular permeability factor/ vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. Journal of Experimental Medicine, 196, 1497-1506.
87. Schmid-Schonbein, G. W. (2003). The second valve system in lymphatics. Lymphatic Research and Biology, 1, 25-29.
88. Jain, R. K., & Fenton, B. T. (2002). Intratumoral lymphatic vessels: A case of mistaken identity or malfunction? Journal of National Cancer Institute, 94, 417-421.
89. Wong, S. Y., Haack, H., Crowley, D., Barry, M., Bronson, R. T., & Hynes, R. O. (2005). Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Research, 65, 9789-9798.
90. Hall, F. T., Freeman, J. L., Asa, S. L., Jackson, D. G., & Beasley, N. J. (2003). Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Archives of Otolaryngology - Head & Neck Surgery, 129, 716-719.
91. Straume, O., Jackson, D. G., & Akslen, L. A. (2003). Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clinical Cancer Research, 9, 250-256.
92. Munoz-Guerra, M. F., Marazuela, E. G., Martin-Villar, E., Quintanilla, M., & Gamallo, C. (2004). Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer, 100, 553-560.
93. Bono, P., Wasenius, V. M., Heikkila, P., Lundin, J., Jackson, D. G., & Joensuu, H. (2004). High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clinical Cancer Research, 10, 7144-7149.
94. Vleugel, M. M., Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Stel, H. V., et al. (2004). Lack of lymphangiogenesis during breast carcinogenesis. Journal of Clinical Pathology, 57, 746-751.
95. Sipos, B., Klapper, W., Kruse, M. L., Kalthoff, H., Kerjaschki, D., & Kloppel, G. (2004). Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. American Journal of Pathology, 165, 1187-1197.
96. Franchi, A., Gallo, O., Massi, D., Baroni, G., & Santucci, M. (2004). Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer, 101, 973-978.
97. Franchi, A., Massi, D., Santucci, M., Masini, E., Degl'Innocenti, D. R., Magnelli, L., et al. (2006). Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. Journal of Pathology, 208, 439-445.
98. Fiedler, U., Christian, S., Koidl, S., Kerjaschki, D., Emmett, M. S., Bates, D. O., et al. (2006). The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. American Journal of Pathology, 168, 1045-1053.
99. Stefansson, I. M., Salvesen, H. B., & Akslen, L. A. (2006). Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Research, 66, 3303-3309.
100. Pepper, M. S., & Skobe, M. (2003). Lymphatic endothelium: Morphological, molecular and functional properties. Journal of Cell Biology, 163, 209-213.
101. Cassella, M., & Skobe, M. (2002). Lymphatic vessel activation in cancer. Annals of the New York Academy of Sciences, 979, 120-130.
102. Mattila, M. M., Ruohola, J. K., Karpanen, T., Jackson, D. G., Alitalo, K., & Harkonen, P. L. (2002). VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. International Journal of Cancer, 98, 946-951.
103. Allan, A. L., George, R., Vantyghem, S. A., Lee, M. W., Hodgson, N. C., Engel, C. J., et al. (2006). Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. American Journal of Pathology, 169, 233-246.
104. Clarijs, R., Ruiter, D. J., & de Waal, R. M. (2001). Lymphangiogenesis in malignant tumours: Does it occur? Journal of Pathology, 193, 143-146.
105. Cursiefen, C., Chen, L., Borges, L. P., Jackson, D., Cao, J., Radziejewski, C., et al. (2004). VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. Journal of the Clinical Investigation, 113, 1040-1050.
106. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., et al. (1999). VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. American Journal of Pathology, 154, 1381-1390.
107. Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y., & Hirohashi, S. (2000). Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clinical Cancer Research, 6, 2431-2439.
108. Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., et al. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proceedings of the National Academy of Sciences of the United States of America, 95, 548-553.
109. Stearns, M. E., Wang, M., Hu, Y., Kim, G., & Garcia, F. U. (2004). Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t (Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis. Laboratory Investigation, 84, 785-795.
110. Kramer, R. H., Shen, X., & Zhou, H. (2005). Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Reviews, 24, 35-45.
111. Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000). Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nature Medicine, 6, 100-102.
112. Liotta, L. A., & Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature, 411, 375-379.
113. Birner, P., Schindl, M., Obermair, A., Breitenecker, G., Kowalski, H., & Oberhuber, G. (2001). Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. International Journal of Cancer, 95, 29-33.
114. Cuenca, A., Cheng, F., Wang, H., Brayer, J., Horna, P., Gu, L., et al. (2003). Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: Dominant role of cross-tolerance to tumor antigens. Cancer Research, 63, 9007-9015.
115. Clark, W. H. Jr, Elder, D. E., Guerry IV, D., Braitman, L. E., Trock, B. J., Schultz, D., et al. (1989). Model predicting survival in stage I melanoma based on tumor progression. Journal of National Cancer Institute, 81, 1893-1904.
116. Kitadai, Y., Kodama, M., Cho, S., Kuroda, T., Ochiumi, T., Kimura, S., et al. (2005). Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. International Journal of Cancer, 115, 388-392.
117. Mouta Carreira, C., Nasser, S. M., di Tomaso, E., Padera, T. P., Boucher, Y., Tomarev, S. I., et al. (2001). LYVE-1 is not restricted to the lymph vessels: Expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Research, 61, 8079-8084.
118. Trojan, L., Michel, M. S., Rensch, F., Jackson, D. G., Alken, P., & Grobholz, R. (2004). Lymph and blood vessel architecture in benign and malignant prostatic tissue: Lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). Journal of Urology, 172, 103-107.
119. Borgstein, P. J., Pijpers, R., Comans, E. F., van Diest, P. J., Boom, R. P., & Meijer, S. (1998). Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. Journal of the American College of Surgeons, 186, 275-283.
120. Hofmann, U. B., Westphal, J. R., Van Muijen, G. N., & Ruiter, D. J. (2000). Matrix metalloproteinases in human melanoma. Journal of Investigative Dermatology, 115, 337-344.